Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Analytical and Bioanalytical Chemistry
|
November 29, 2019
The utility of asymmetric flow field-flow fractionation for preclinical characterization of nanomedicines
Yingwen Hu, Rachael M Crist, Jeffrey D Clogston
The AAPS Journal
|
October 12, 2017
Nanotechnology as a Delivery Tool for Precision Cancer Therapies
Bhawna Sharma, Rachael M Crist, Pavan P Adiseshaiah
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2017
Evaluating Nanomedicines: Obstacles and Advancements
Magdalena Swierczewska, Rachael M Crist, Scott E McNeil
Molecules (Basel, Switzerland)
|
January 5, 2021
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
David M Stevens, Rachael M Crist, Stephan T Stern
Particle and Fibre Toxicology
|
June 16, 2012
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity
Stephan T Stern, Pavan P Adiseshaiah, Rachael M Crist
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2022
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
Ruvanthi N Kularatne, Rachael M Crist, Stephan T Stern
The AAPS Journal
|
September 11, 2016
Early Development Challenges for Drug Products Containing Nanomaterials
Jennifer H Grossman, Rachael M Crist, Jeffrey D Clogston
Journal of Pharmaceutical and Biomedical Analysis
|
December 4, 2018
Ion quantification in liposomal drug products using high performance liquid chromatography
Jiewei Wu, Rachael M Crist, Scott E McNeil, et al.
Nature Reviews. Clinical Oncology
|
August 18, 2016
Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
Pavan P Adiseshaiah, Rachael M Crist, Sara S Hook, et al.
Analytical and Bioanalytical Chemistry
|
August 2, 2017
Zeta potential: a case study of cationic, anionic, and neutral liposomes
Mackensie C Smith, Rachael M Crist, Jeffrey D Clogston, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Analytical and Bioanalytical Chemistry
|
November 29, 2019
The utility of asymmetric flow field-flow fractionation for preclinical characterization of nanomedicines
Yingwen Hu, Rachael M Crist, Jeffrey D Clogston
The AAPS Journal
|
October 12, 2017
Nanotechnology as a Delivery Tool for Precision Cancer Therapies
Bhawna Sharma, Rachael M Crist, Pavan P Adiseshaiah
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2017
Evaluating Nanomedicines: Obstacles and Advancements
Magdalena Swierczewska, Rachael M Crist, Scott E McNeil
Molecules (Basel, Switzerland)
|
January 5, 2021
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
David M Stevens, Rachael M Crist, Stephan T Stern
Particle and Fibre Toxicology
|
June 16, 2012
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity
Stephan T Stern, Pavan P Adiseshaiah, Rachael M Crist
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2022
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
Ruvanthi N Kularatne, Rachael M Crist, Stephan T Stern
The AAPS Journal
|
September 11, 2016
Early Development Challenges for Drug Products Containing Nanomaterials
Jennifer H Grossman, Rachael M Crist, Jeffrey D Clogston
Journal of Pharmaceutical and Biomedical Analysis
|
December 4, 2018
Ion quantification in liposomal drug products using high performance liquid chromatography
Jiewei Wu, Rachael M Crist, Scott E McNeil, et al.
Nature Reviews. Clinical Oncology
|
August 18, 2016
Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
Pavan P Adiseshaiah, Rachael M Crist, Sara S Hook, et al.
Analytical and Bioanalytical Chemistry
|
August 2, 2017
Zeta potential: a case study of cationic, anionic, and neutral liposomes
Mackensie C Smith, Rachael M Crist, Jeffrey D Clogston, et al.
Page
of 4